CareCloud Stock - analyst estimates and sector comparison at week’s end

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 20:22 UTC. Details in the imprint.

CareCloud (US14169G1058) is a small health IT and practice-management stock on Nasdaq. With no new SEC filings, earnings releases or major wire reports on 06/19/2026, the focus for investors shifts to analyst expectations and how the wider digital health peer group has traded this week.

What current data show

CareCloud last reported quarterly figures for its first quarter of 2025 on 05/13/2025, posting revenue of roughly $27 million and an adjusted EBITDA margin in the mid-single digits, according to the company’s IR release for Q1 2025.

Management at that time highlighted subscription-based revenue from its cloud platform as a stabilizing factor while also noting continued cost discipline in sales and marketing. The release underlined a focus on recurring revenue and cross-selling across its installed base.

Analyst estimates and rating picture

Analyst coverage on CareCloud is sparse for a Nasdaq-listed name of this size, with only a small number of brokerage houses regularly updating earnings and price targets. Public consensus data from aggregators such as MarketWatch and Yahoo Finance typically list one to two active analyst ratings for the stock.

Available estimates point to modest revenue growth from the 2024 base and a gradual improvement in profitability metrics over the next few years, reflecting expectations that SaaS and RCM contracts can scale with relatively limited incremental cost.

How the sector traded this week

The broader US healthcare IT and digital health universe, including names such as NextGen Healthcare, Phreesia and Teladoc, showed mixed trading this week, with many shares reacting more to interest-rate expectations and risk appetite than to company-specific news.

Within that context, smaller-cap software-driven providers of electronic health record tools, revenue-cycle outsourcing and telehealth platforms continue to exhibit higher day-to-day volatility than large pharmaceutical or medical device stocks, simply because liquidity is thinner and single orders can move the quote.

What the company sells

CareCloud generates its revenue by providing cloud-based practice management, electronic health record software and revenue cycle management services to physician practices and medical groups. Its portfolio spans front-office scheduling tools, clinical documentation platforms and billing services delivered on a subscription and transaction-fee basis.

Where the stock trades today

The shares of CareCloud (US14169G1058) trade on Nasdaq in the United States; a reliable consolidated quote was not available at 06/19/2026, 20:22 UTC, so no current price in USD can be stated here.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.